David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
CALL
Tapestry
TPR
$26.4B
| $19.7M | 0.01% |
224,200
+81,500
| +57% | +$6.17M |
|
977
Encompass Health
EHC
$11.9B
| $19.7M | 0.01% |
160,387
+103,391
| +181% | +$11.8M |
|
978
Ultragenyx Pharmaceutical
RARE
$2.54B
| $19.7M | 0.01% |
540,801
-15,616
| -3% | -$563K |
|
|
B
979
Barrick Mining
B
$79.3B
| $19.6M | 0.01% |
940,003
-3,919,759
| -81% | -$76.6M |
|
980
Antero Midstream
AM
$10.5B
| $19.6M | 0.01% |
1,032,095
+614,860
| +147% | +$11M |
|
981
Chemed
CHE
$7.08B
| $19.5M | 0.01% |
40,129
-3,519
| -8% | -$2.01M |
|
982
Oscar Health
OSCR
$9.82B
| $19.5M | 0.01% |
910,698
+615,207
| +208% | +$9.15M |
|
|
UCTT
983
Ultra Clean Holdings
UCTT
$3.3B
| $19.5M | 0.01% |
864,258
+308,540
| +56% | +$6.33M |
|
984
Dentsply Sirona
XRAY
$2.17B
| $19.5M | 0.01% |
1,227,216
-118,373
| -9% | -$1.77M |
|
985
CALL
Lowe's Companies
LOW
$122B
| $19.5M | 0.01% |
87,800
| – | – |
|
986
Core & Main
CNM
$8.31B
| $19.4M | 0.01% |
322,158
-298,521
| -48% | -$16M |
|
987
Primerica
PRI
$9.23B
| $19.4M | 0.01% |
71,019
+20,909
| +42% | +$5.54M |
|
988
BJ's Restaurants
BJRI
$1.43B
| $19.4M | 0.01% |
435,623
+141,700
| +48% | +$5.59M |
|
989
PUT
Constellation Brands
STZ
$23.5B
| $19.4M | 0.01% |
119,200
+65,200
| +121% | +$11.7M |
|
990
PUT
Royal Caribbean
RCL
$78.4B
| $19.4M | 0.01% |
61,900
-44,700
| -42% | -$10.6M |
|
991
Fox Class A
FOXA
$29B
| $19.4M | 0.01% |
345,636
-99,968
| -22% | -$5.27M |
|
992
PUT
First Citizens BancShares
FCNCA
$24.7B
| $19.4M | 0.01% |
9,900
-2,000
| -17% | -$3.63M |
|
|
CYBR
993
DELISTED
CyberArk
CYBR
| $19.1M | 0.01% |
46,980
-4,263
| -8% | -$1.55M |
|
994
Campbell Soup
CPB
$7.2B
| $19.1M | 0.01% |
+622,710
| New | +$21.9M |
|
995
CALL
Astera Labs
ALAB
$48.1B
| $19.1M | 0.01% |
210,700
-117,700
| -36% | -$9.3M |
|
996
PUT
Southwest Airlines
LUV
$19.9B
| $19M | 0.01% |
586,100
+566,100
| +2,831% | +$17.1M |
|
997
Moody's
MCO
$88.6B
| $19M | 0.01% |
37,837
+16,394
| +76% | +$7.59M |
|
998
A.O. Smith
AOS
$8.52B
| $18.9M | 0.01% |
288,943
+177,249
| +159% | +$11.6M |
|
999
PUT
Enphase Energy
ENPH
$4.91B
| $18.9M | 0.01% |
477,800
-119,300
| -20% | -$5.51M |
|
1000
Radian Group
RDN
$4.86B
| $18.9M | 0.01% |
524,744
+190,955
| +57% | +$6.38M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.